✦ LIBER ✦

Effects on turning of microinjections into basal ganglia of D1 and D2 dopamine receptors agonists and the cannabinoid CB1 antagonist SR141716A in a rat Parkinson's model

✍ Scribed by Fadwa El Banoua; Isabel Caraballo; Juan A Flores; Beatriz Galan-Rodriguez; Emilio Fernandez-Espejo

Book ID: 116761601
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 392 KB
Volume: 16
Category: Article
ISSN: 0969-9961
DOI: 10.1016/j.nbd.2004.03.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of the cannabinoid CB1receptor an

Effect of the cannabinoid CB1receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats

✍ Daina Economidou; Laura Mattioli; Carlo Cifani; Marina Perfumi; Maurizio Massi; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 189 KB

Acute effects of D-1 and D-2 dopamine re

Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat

✍ Michael D. Taylor; Maria L. de Ceballos; Peter Jenner; C.David Marsden 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 906 KB

Effects of specific dopamine D1 and D2 r

Effects of specific dopamine D1 and D2 receptor antagonists and agonists and neuroleptic drugs on emotional defecation in a rat model of akathisia

✍ Perminder S Sachdev; Tanya Saharov 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Differential interaction of competitive

Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease

✍ Peter-Andreas Löschmann; Ullrich Wüllner; Michael T. Heneka; Jörg B. Schulz; Mar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 3 views

1-aminomethyl-5,6-dihydroxy-3-phenylisochroman; NMDA antagonist; CPP; 3-((6)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid

The decrease of dopamine D2/D3 receptor

The decrease of dopamine D2/D3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB1 cannabinoid receptors in Parkinson's disease: A preliminary autoradiographic study with the selective dopamine D2/D3 antagonist [3H]raclopride and the novel CB1 inverse agonist [125I]SD7015

✍ Szabolcs Farkas; Katalin Nagy; Zhisheng Jia; Tibor Harkany; Miklós Palkovits; Se 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 745 KB

Effect of GLC756, a novel mixed dopamine

Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells

✍ Ulrich Wilhelm Laengle; Rudolf Markstein; Dominique Pralet; Wolfgang Seewald; Da 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 160 KB